THE RITEDOSE CORPORATION

Lobbying client · South Carolina · filed 2025 to 2026

Pharmaceutical CDMO and Generics Manufacturer.

$330,000 Reported spend

5 Filings counted

1 Firms hired

0 Bills named

Spend is reported income plus in-house expenses across 5 filings. Everything on this page is grouped by the client's LDA id (68586), not by name.

Firms hired 1

SALT POINT STRATEGIES $330,000 5 filings

Reported by year 2 years

2026 $180,000 2 filings
2025 $150,000 3 filings

Issues lobbied 3

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 4

HOUSE OF REPRESENTATIVES 4
SENATE 4
Commerce, Dept of (DOC) 1
Executive Office of the President (EOP) 1

Recent filings 5 total

Q2

SALT POINT STRATEGIES

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $90,000 income · posted Jul 20, 2026

View → Q1

SALT POINT STRATEGIES

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $90,000 income · posted Apr 17, 2026

View → Q4

SALT POINT STRATEGIES

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $90,000 income · posted Jan 18, 2026

View → Q3

SALT POINT STRATEGIES

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $60,000 income · posted Oct 20, 2025

View → RR

SALT POINT STRATEGIES

3rd Quarter (July 1 - Sep 30) 2025 · posted Sep 7, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.